Results 321 to 330 of about 147,268 (335)
Some of the next articles are maybe not open access.
Can von Willebrand Disease Be Investigated on Combined Hormonal Contraceptives?
Journal of Pediatric and Adolescent Gynecology, 2013Tania Dumont, Lisa Allen
exaly
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Nature Reviews Nephrology, 2012M. Noris, Federica Mescia, G. Remuzzi
semanticscholar +1 more source
Therapeutic RNA aptamers in clinical trials.
European Journal of Pharmaceutical Sciences, 2013P. Sundaram +3 more
semanticscholar +1 more source
Variability of von Willebrand factor‐related parameters in endothelial colony forming cells
Journal of Thrombosis and Haemostasis, 2019A De Jong +2 more
exaly
Von Willebrand factor and von Willebrand disease
Von Willebrand disease (vWD) is an autosomally inherited bleeding disorder caused by a deficiency or abnormality of von Willebrand factor (vWF). vWF is a large multimeric glycoprotein that mediates platelet adhesion at the site of vessel injury. Also, it protects factor VIII from proteolytic degradation in the circulation. vWD has a prevalence of aboutopenaire +1 more source

